Performance
2026

1.35%0.00-1.35%
1.35%
February 2026
-0.41%
January 2026
Dec December
Nov November
Oct October
Sep September
Aug August
Jul July
Jun June
May May
Apr April
Mar March
Feb February
Jan January
0.93%
1.35%
-0.41%
2026
14.27%
-0.70%
-0.75%
3.55%
-0.82%
0.12%
2.91%
3.20%
5.00%
-1.32%
0.23%
-0.34%
2.58%
2025
13.60%
-1.69%
1.57%
-1.77%
-0.37%
0.33%
1.33%
2.85%
2.97%
-0.72%
4.24%
3.45%
0.87%
2024
15.87%
1.72%
3.30%
0.89%
-0.50%
-1.26%
1.60%
3.80%
-3.47%
4.83%
2.45%
0.82%
0.93%
2023
3.48%
-2.29%
4.67%
4.12%
-4.82%
-1.99%
5.40%
-5.28%
1.95%
-1.13%
2.85%
0.20%
0.46%
2022
22.74%
4.35%
-2.98%
6.41%
-0.82%
1.83%
2.13%
3.60%
-0.25%
4.50%
3.12%
1.08%
-1.88%
2021
20.89%
2.89%
12.22%
-3.71%
-1.85%
3.41%
0.04%
0.28%
3.71%
3.54%
0.07%
-0.61%
0
2020
0%
0
0
0
0
0
0
0
0
0
0
0
0
2019
0%
0
0
0
0
0
0
0
0
0
0
0
0
2018
20.61%
0
0
0
0
0
0
0
20.61%
2017
Trading since5/19/17 Show More
Past performance is not indicative of future results. Stats are updated on a daily basis at 00:00 GMT.

Breakdown

This breakdown includes 100.0% of this Portfolio

Asset Type

Portfolio Risk (1Y)

Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Avg. Risk Score (last 7D)3
Daily Max. Drawdown-4.48%
Weekly Max. Drawdown-5.86%
Yearly Max. Drawdown-9.59%

Expected Dividends

Dividend Yield

1.02%

4 Assets

Dividend Logo
Dividend Logo
Dividend Logo

+1 more

Trading

479 Total Trades (12M)
43.02% Avg. Profit
-6.32% Avg. Loss
91.44% Profitable Trades

Frequently Traded

MSFT
50.74% Avg. Profit
-8.69% Avg. Loss
72.16%Profitable
SHEL.L
58.90% Avg. Profit
-0.46% Avg. Loss
97.94%Profitable
KO
35.04% Avg. Profit
0% Avg. Loss
100.00%Profitable

Additional Stats

8.71
Trades Per Week
41 Months Avg. Holdings time
5/19/17 Active since
57.41% Profitable weeks

Copiers (12M)

2
Content, research, tools, and stock symbols on eToro's website are for educational purposes only and do not imply a recommendation or solicitation to engage in any specific investment strategy. All investments involve risk, losses may exceed the amount of principal invested, and past performance does not guarantee future results.